Human Papillomavirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Human Papillomavirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global Human Papillomavirus (HPV) testing market is on a trajectory to reach almost US$ 1,130 million by the end of 2025. This remarkable growth is driven by several key factors:

Favorable Reimbursement Scenario in North America

In North America, the HPV testing market benefits from a favorable reimbursement landscape. Various healthcare and government insurance providers offer reimbursement for the diagnosis of chronic disorders such as cervical cancer. For instance, Medicare, the U.S. government-funded health insurance provider, provides reimbursement to individuals aged 65 or older and some young people with disabilities. Medicare also covers reimbursement for one Pap test every three years or a combination of Pap test and HPV testing every five years for cervical cancer diagnosis. Additionally, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in the United States offers free or low-cost breast and cervical cancer screening for uninsured women, further boosting HPV testing adoption.

High Sensitivity of HPV Testing in Low Resource Settings Drives Growth in Latin America

Developing countries face significant challenges in establishing cytology-based screening programs due to limited capacity and resources.This high sensitivity allows for increased screening intervals and broader coverage in high-risk populations. In low-resource settings where cytology-based programs have faltered, HPV testing emerges as a more effective alternative, contributing to market growth, particularly in Latin America.

Gender-Specific Limitations Impact Market Growth

Despite the prevalence of HPV infections in men, there is currently no HPV test recommended for them. HPV infections can affect men in various ways, including genital warts, anal cancers, penile cancers, and oropharyngeal cancers. Approved HPV tests available in the market are primarily designed for cervical cancer screening in women. This gender-specific limitation has restricted market growth to a particular demographic, hindering its overall expansion.

Regional Market Attractiveness Analysis

Europe is expected to be a significant market during the forecast period, while the Latin America HPV testing market, though less attractive currently, is projected to gain a notable market share by 2031. In the Asia Pacific region, HPV testing is forecasted to gradually increase its revenue share. Conversely, the Middle East and Africa (MEA) is expected to be the least attractive market for HPV testing over the forecast period.

Shift Towards HPV Testing Over Pap Smear Tests

In North America, there has been a noticeable shift in the adoption rate of HPV diagnostic testing for cervical cancer screening over traditional Pap smear tests. While Pap cytology-based testing was once the primary method, it is associated with limitations such as high variability in results, low reproducibility, low specificity, and the need for frequent testing. HPV testing, with its high sensitivity, is gaining preference as a more reliable and accurate screening method.

Market Segmentation

The HPV testing market is segmented by product type, end-users, applications, and regions:

Product Type:
• DNA-based tests
• RNA-based tests

End-users:
• Hospitals
• Clinics
• Diagnostic centers
• Research institutes

Applications:
• Molecular diagnostics
• Research use

Regions:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

With growing awareness, evolving healthcare policies, and advancements in testing technology, the global HPV testing market is poised for significant expansion in the coming years.

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Human Papillomavirus Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Human Papillomavirus Testing Market Outlook, 2018 – 2031
3.1. Global Human Papillomavirus Testing Market Outlook, by Product, Value (US$ Mn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. DNA-based Test
3.1.1.2. RNA-based Test
3.2. Global Human Papillomavirus Testing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Molecular Diagnostics
3.2.1.2. Research Use
3.3. Global Human Papillomavirus Testing Market Outlook, by End User, Value (US$ Mn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Clinics
3.3.1.3. Diagnostic Centres
3.3.1.4. Research Institutes
3.4. Global Human Papillomavirus Testing Market Outlook, by Region, Value (US$ Mn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Human Papillomavirus Testing Market Outlook, 2018 – 2031
4.1. North America Human Papillomavirus Testing Market Outlook, by Product, Value (US$ Mn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. DNA-based Test
4.1.1.2. RNA-based Test
4.2. North America Human Papillomavirus Testing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Molecular Diagnostics
4.2.1.2. Research Use
4.3. North America Human Papillomavirus Testing Market Outlook, by End User, Value (US$ Mn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Clinics
4.3.1.3. Diagnostic Centres
4.3.1.4. Research Institutes
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Human Papillomavirus Testing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
4.4.1.2. U.S. Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
4.4.1.3. U.S. Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
4.4.1.4. Canada Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
4.4.1.5. Canada Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
4.4.1.6. Canada Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Human Papillomavirus Testing Market Outlook, 2018 – 2031
5.1. Europe Human Papillomavirus Testing Market Outlook, by Product, Value (US$ Mn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. DNA-based Test
5.1.1.2. RNA-based Test
5.2. Europe Human Papillomavirus Testing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Molecular Diagnostics
5.2.1.2. Research Use
5.3. Europe Human Papillomavirus Testing Market Outlook, by End User, Value (US$ Mn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Clinics
5.3.1.3. Diagnostic Centres
5.3.1.4. Research Institutes
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Human Papillomavirus Testing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Germany Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.2. Germany Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.3. Germany Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.1.4. U.K. Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.5. U.K. Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.6. U.K. Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.1.7. France Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.8. France Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.9. France Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.1.10. Italy Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.11. Italy Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.12. Italy Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.1.13. Turkey Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.14. Turkey Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.15. Turkey Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.1.16. Russia Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.17. Russia Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.18. Russia Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.1.19. Rest of Europe Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
5.4.1.20. Rest of Europe Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
5.4.1.21. Rest of Europe Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Human Papillomavirus Testing Market Outlook, 2018 – 2031
6.1. Asia Pacific Human Papillomavirus Testing Market Outlook, by Product, Value (US$ Mn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. DNA-based Test
6.1.1.2. RNA-based Test
6.2. Asia Pacific Human Papillomavirus Testing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Molecular Diagnostics
6.2.1.2. Research Use
6.3. Asia Pacific Human Papillomavirus Testing Market Outlook, by End User, Value (US$ Mn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Clinics
6.3.1.3. Diagnostic Centres
6.3.1.4. Research Institutes
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Human Papillomavirus Testing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. China Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
6.4.1.2. China Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
6.4.1.3. China Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
6.4.1.4. Japan Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
6.4.1.5. Japan Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
6.4.1.6. Japan Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
6.4.1.7. South Korea Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
6.4.1.8. South Korea Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
6.4.1.9. South Korea Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
6.4.1.10. India Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
6.4.1.11. India Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
6.4.1.12. India Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
6.4.1.13. Southeast Asia Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
6.4.1.14. Southeast Asia Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
6.4.1.15. Southeast Asia Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
6.4.1.16. Rest of Asia Pacific Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
6.4.1.17. Rest of Asia Pacific Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
6.4.1.18. Rest of Asia Pacific Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Human Papillomavirus Testing Market Outlook, 2018 – 2031
7.1. Latin America Human Papillomavirus Testing Market Outlook, by Product, Value (US$ Mn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. DNA-based Test
7.1.1.2. RNA-based Test
7.2. Latin America Human Papillomavirus Testing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
7.2.1.1. Molecular Diagnostics
7.2.1.2. Research Use
7.3. Latin America Human Papillomavirus Testing Market Outlook, by End User, Value (US$ Mn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Clinics
7.3.1.3. Diagnostic Centres
7.3.1.4. Research Institutes
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Human Papillomavirus Testing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
7.4.1.2. Brazil Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
7.4.1.3. Brazil Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
7.4.1.4. Mexico Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
7.4.1.5. Mexico Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
7.4.1.6. Mexico Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
7.4.1.7. Argentina Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
7.4.1.8. Argentina Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
7.4.1.9. Argentina Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
7.4.1.10. Rest of Latin America Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
7.4.1.11. Rest of Latin America Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
7.4.1.12. Rest of Latin America Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Human Papillomavirus Testing Market Outlook, 2018 – 2031
8.1. Middle East & Africa Human Papillomavirus Testing Market Outlook, by Product, Value (US$ Mn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. DNA-based Test
8.1.1.2. RNA-based Test
8.2. Middle East & Africa Human Papillomavirus Testing Market Outlook, by Application, Value (US$ Mn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Molecular Diagnostics
8.2.1.2. Research Use
8.3. Middle East & Africa Human Papillomavirus Testing Market Outlook, by End User, Value (US$ Mn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Clinics
8.3.1.3. Diagnostic Centres
8.3.1.4. Research Institutes
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Human Papillomavirus Testing Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. GCC Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
8.4.1.2. GCC Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
8.4.1.3. GCC Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
8.4.1.4. South Africa Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
8.4.1.5. South Africa Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
8.4.1.6. South Africa Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
8.4.1.7. Egypt Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
8.4.1.8. Egypt Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
8.4.1.9. Egypt Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
8.4.1.10. Nigeria Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
8.4.1.11. Nigeria Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
8.4.1.12. Nigeria Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
8.4.1.13. Rest of Middle East & Africa Human Papillomavirus Testing Market by Product, Value (US$ Mn), 2018 – 2031
8.4.1.14. Rest of Middle East & Africa Human Papillomavirus Testing Market by Application, Value (US$ Mn), 2018 – 2031
8.4.1.15. Rest of Middle East & Africa Human Papillomavirus Testing Market by End User, Value (US$ Mn), 2018 – 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. F. Hoffmann-La Roche Ltd.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Agilent Technologies, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Becton, Dickinson and Company
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Qiagen N.V.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Thermo Fisher Scientific Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Abbott Laboratories
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Hologic Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Cepheid Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Seegene Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Takara Bio Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings